MedTrace Logo

Long-Term Efficacy in AMD of Rheopheresis in North America

NCT00380172 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2006-09-25

No results posted yet for this study

Summary

The purpose of these studies are to evaluate the effect on vision in subjects with AMD who received active and placebo treatment in the MIRA-1 study.

Conditions

  • Macular Degeneration

Interventions

DEVICE

Rheopheresis blood filtration

Sponsors & Collaborators

  • OccuLogix

    lead INDUSTRY

Principal Investigators

  • Nozhat Choudry', Ph.D. · OccuLogix, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
0 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-10-31
Completion
2007-10-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00380172 on ClinicalTrials.gov